Rocket Doctor AI (TRUE.CN) Stock Price
Rocket Doctor AI Price
Rocket Doctor AI stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Rocket Doctor AI business model & stock analysis
Frequently asked questions about Rocket Doctor AI
7 analysts currently rate the Rocket Doctor AI stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Rocket Doctor AI to generate revenue of 1.65 B CAD and earnings per share of -0.28 CAD.
The Rocket Doctor AI share (TRUE.CN) is listed on 3 stock exchanges, including: Frankfurt (939.F), München (939.MU).
The expected revenue of Rocket Doctor AI is 1.65 B CAD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Rocket Doctor AI is -12.38 M CAD. The net profit reflects the company's profitability after deducting all expenses.
The P/E ratio cannot be calculated for Rocket Doctor AI at the moment.
The P/S cannot be calculated for Rocket Doctor AI currently.
The Eulerpool Quality Score for Rocket Doctor AI is 2/10.
The ISIN of Rocket Doctor AI is CA7729241066. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Rocket Doctor AI is A3EYD8. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Rocket Doctor AI is TRUE.CN. The ticker symbol is used to trade Rocket Doctor AI shares on the stock exchange.
Rocket Doctor AI stock
Rocket Doctor AI Peer Group
Rocket Doctor AI Ticker
All fundamentals and in-depth analysis of Rocket Doctor AI
Our stock analysis for Rocket Doctor AI stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Rocket Doctor AI. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.